INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 1 filers reported holding INTERSECT ENT INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $36,000 | +1700.0% | 1,319 | +1868.7% | 0.00% | – |
| Q4 2021 | $2,000 | -100.0% | 67 | -100.0% | 0.00% | -100.0% |
| Q2 2021 | $59,473,000 | +3.3% | 3,480,000 | +26.2% | 0.01% | 0.0% |
| Q1 2021 | $57,595,000 | -15.0% | 2,758,351 | -6.8% | 0.01% | -16.7% |
| Q4 2020 | $67,784,000 | +50.0% | 2,960,000 | +6.9% | 0.01% | +20.0% |
| Q3 2020 | $45,179,000 | +99.8% | 2,770,000 | +65.9% | 0.01% | +150.0% |
| Q2 2020 | $22,612,000 | +20.7% | 1,670,000 | +5.6% | 0.00% | -33.3% |
| Q1 2020 | $18,735,000 | – | 1,580,963 | +79048050.0% | 0.00% | – |
| Q4 2019 | $0 | – | 2 | -50.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 4 | -100.0% | 0.00% | -100.0% |
| Q2 2019 | $14,828,000 | -27.1% | 651,502 | +3.0% | 0.00% | 0.0% |
| Q1 2019 | $20,334,000 | +2139.4% | 632,451 | +1863.8% | 0.00% | – |
| Q4 2018 | $908,000 | -65.6% | 32,205 | -64.9% | 0.00% | – |
| Q3 2018 | $2,641,000 | -93.4% | 91,873 | -91.4% | 0.00% | -100.0% |
| Q2 2018 | $40,007,000 | +28.0% | 1,068,280 | +34.3% | 0.01% | +25.0% |
| Q1 2018 | $31,259,000 | -26.0% | 795,400 | -39.0% | 0.00% | -20.0% |
| Q4 2017 | $42,250,000 | -44.0% | 1,304,036 | -46.2% | 0.01% | -44.4% |
| Q3 2017 | $75,496,000 | +82.2% | 2,423,626 | +63.4% | 0.01% | +80.0% |
| Q2 2017 | $41,447,000 | +466.6% | 1,482,909 | +247.7% | 0.01% | +400.0% |
| Q1 2017 | $7,315,000 | +403.8% | 426,520 | +255.4% | 0.00% | – |
| Q4 2016 | $1,452,000 | – | 120,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|